U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07516145) titled 'Robotic Transjugular Transcatheter Tricuspid Valve Replacement' on March 31.
Brief Summary: Valvular heart disease (VHD), caused by abnormalities in heart valves, can lead to severe complications such as heart failure and death, with approximately 220 million affected patients worldwide. The prevalence of VHD continues to grow alongside the aging global population. Transcatheter heart valve interventions have emerged as minimally invasive alternatives, offering benefits like shorter recovery times and reduced discomfort. However, current manual catheter-based techniques are complex, highly dependent on clinicians' expertise, and inv...